secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001299130-25-000152
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio Q2 revenue up 10.5% YoY to $39.8M; GAAP net loss narrows to $41.9M
-------------------------------------------------------------------------

- GAAP net loss per share of $0.14 improved from $0.64 YoY; non-GAAP EPS -$0.13 vs -$0.20.
- Consumable revenue $18.9M (+11% YoY); service & other revenue $6.7M (+56% YoY).
- Shipped 15 Revio and 38 Vega systems; Revio annualized pull-through ~$219K/system.
- Cash, equivalents, and investments $314.7M, down from $509.8M a year earlier.
- Non-GAAP operating expenses cut to $58.1M from $71.0M YoY; CEO cites disciplined cost management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/0001299130-25-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/pacb-20250807.htm
  HTML page:      https://secwatch.observer/filing/0001299130-25-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer